NCT06142838招募中不适用
Community Pharmacist Intervention to Enhance Adherence in Cardiovascular Drug Initiators
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,600
- 试验地点
- 1
- 主要终点
- NIH Patient Reported Outcomes Measurement Information System (PROMIS) Medication Adherence Scale (PMAS)
研究概览
简要总结
The goal of this clinical trial is to evaluate a community pharmacist intervention aimed at improving medication adherence in patients starting newly prescribed medication for cardiovascular disease prevention. The main questions it aims to answer are:
- Does this community pharmacist intervention improve medication adherence?
- Which patients benefit the most from the intervention?
- How do patients experience the start-up of newly prescribed medication (which questions do they have and do they experience side effects?)?
- How do patients and pharmacists experience the intervention?
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double (Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients presenting with a first prescription for one of the following drug classes: antihypertensive drugs (= low-ceiling diuretics, beta blocking agents (excl. non-selective beta-blocking agents), ACE inhibitors, angiotensin II receptor blockers, calcium channel blockers), lipid-lowering drugs (= statins), antidiabetic drugs (= metformin, glucagon-like peptide-1 (GLP-1) analogues, sodium-glucose co-transporter 2 (SGLT2) inhibitors), or any combination thereof.
- •Age 18 years or older
- •Community-dwelling
排除标准
- •The drug is prescribed for a non-cardiovascular indication (e.g. beta-blocking agent for migraine prophylaxis)
- •Communication with the patient is not possible (e.g. due to cognitive impairment, insufficient knowledge of Dutch or French language)
研究组 & 干预措施
Control arm
No Intervention
Usual care
Intervention arm
Experimental
Community pharmacist intervention
干预措施: community pharmacist intervention (Behavioral)
结局指标
主要结局
NIH Patient Reported Outcomes Measurement Information System (PROMIS) Medication Adherence Scale (PMAS)
时间窗: At 6 weeks and at 12 weeks follow-up
Patient-reported measure of medication adherence
次要结局
- Healthcare utilization(Over 12 weeks post-baseline)
- Medication Possession Ratio (MPR)(Over 26 weeks post-baseline)
- Medication knowledge questionnaire(At 6 weeks and at 12 weeks follow-up)
- Treatment response(At baseline and at 12 weeks follow-up)
- Discontinuation rate(Over 26 weeks post-baseline)
- Beliefs about Medicines Questionnaire (BMQ-Specific)(At 6 weeks and at 12 weeks follow-up)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A Community Pharmacist-led Intervention to Improve Adherence to Lipid-lowering TreatmentHypercholesterolemiaNCT00493337Utrecht Institute for Pharmaceutical Sciences373
Unknown
不适用
A Trial on the Role of Community Pharmacist in Improving Adherence and Clinical Outcomes in Post-InfarctionMyocardial Infarction, AcuteST Segment Elevation Myocardial InfarctionNon-ST Elevation Myocardial Infarction (nSTEMI)NCT03621111Azienda ULSS 5 Polesana120
已完成
不适用
Implementation of a Pharmacy-Intervention to Enhance Prescription and Use of Lipid-Lowering DrugsCardiovascular DiseasesNCT00509717Radboud University Medical Center70
已完成
不适用
Pharmacy Implementation Trial: Adherence to Antihypertensive TherapyHypertensionNCT00460343Radboud University Medical Center57
招募中
不适用
Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in AppalachiaSmoking CessationSmoking, CigaretteSmoking ReductionSmokingSmoking, TobaccoQuitting SmokingNCT05660525University of Virginia768